Telehealth Anxiety Prescribing: What PMHNPs Can Do

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can build a thriving telehealth practice treating anxiety — or you’re trying to understand the patchwork of state laws around virtual prescribing — you’ve come to the right place.

The short answer: Yes, psychiatrists can prescribe anxiety medications via telehealth in 2026, including controlled substances like benzodiazepines. But the rules vary significantly by state, provider type, and insurance coverage. This guide breaks down exactly what you can do, where you can do it, and how the economics actually work.

What You Can Actually Prescribe for Anxiety via Telehealth

As a psychiatrist (MD/DO), you have unrestricted prescribing authority in all 50 states. That means you can prescribe:

• SSRIs and SNRIs (sertraline, escitalopram, venlafaxine) — first-line treatments
• Benzodiazepines (alprazolam, clonazepam, lorazepam) — Schedule IV controlled substances
• Buspirone, hydroxyzine, beta-blockers — non-controlled anxiolytics
• Off-label medications when clinically appropriate

The federal telemedicine flexibilities introduced during COVID have been extended through December 2026, allowing you to prescribe controlled substances via telehealth without requiring an initial in-person visit. This was a critical extension — over 7 million controlled substance prescriptions for conditions like anxiety and ADHD were written via telemedicine in 2024 alone.

What this means practically: You can conduct a comprehensive psychiatric evaluation over video, diagnose generalized anxiety disorder or panic disorder, and initiate treatment with an SSRI or benzodiazepine — all without ever meeting the patient face-to-face. The DEA and HHS are working on permanent regulations to replace these temporary rules, expected late 2026, but for now the pathway is clear.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The PMHNP Story: It Depends Where You Practice

For Psychiatric Mental Health Nurse Practitioners, prescribing authority for anxiety medications is more complex and varies dramatically by state.

Full Practice Authority States (PMHNPs = Psychiatrists)

In states like New York, Arizona, Oregon, and Washington, PMHNPs can evaluate, diagnose, and prescribe anxiety medications — including controlled substances — completely independently.

New York’s 2022 transformation is the standout example. The state eliminated the collaborative agreement requirement entirely. A PMHNP in NYC can now open their own telepsychiatry practice, manage patients with panic disorder, prescribe Xanax for acute anxiety, and bill insurance directly — no psychiatrist oversight needed. The only difference from a psychiatrist is the 85% Medicare reimbursement rate (more on that below) and the NP credential itself.

The Collaboration States (Most of the Country)

Texas, Florida, Pennsylvania, and Illinois all require some level of physician involvement for PMHNPs:

Texas is particularly restrictive: PMHNPs must maintain a Prescriptive Authority Agreement with a physician. They can prescribe benzodiazepines for anxiety if their delegating physician authorizes it, but they cannot prescribe Schedule II stimulants outside hospital settings (relevant if treating comorbid ADHD). The supervising physician doesn’t co-sign every prescription, but they must review charts periodically and be available for consultation.

Florida requires PMHNPs to practice under written protocols with a physician. Here’s the key detail: Florida limits NP controlled substance prescriptions to 7 days — unless you’re a psychiatric nurse practitioner treating a mental health condition. That carve-out means Florida PMHNPs can prescribe a full month of Xanax for anxiety disorder, but only if their protocol allows it and they’re board-certified in psychiatric nursing.

Pennsylvania mandates collaborative agreements where the physician must review at least 10% of charts (100% for Schedule II prescriptions). For anxiety treatment, this means a PMHNP can manage SSRIs fairly independently, but benzodiazepine prescriptions should fall within the collaborative scope, and the physician needs to be looped in.

Illinois offers a middle path: new PMHNPs need collaboration, but after 4,000 clinical hours and 250 continuing education hours, they can apply for Full Practice Authority. Even then, they need a one-time physician sign-off to prescribe controlled substances — essentially a formal acknowledgment that benzos and Schedule II drugs are in their scope.

California’s Transition (2023-2026)

California is mid-shift. Until 2023, all NPs needed physician-supervised standardized procedures. AB 890 created two new categories:

• 103 NPs (since Jan 2023): Can practice without standardized procedures within a group practice that includes at least one physician
• 104 NPs (starting Jan 2026): Full independent practice after 3 years as a 103 NP

This means experienced California PMHNPs will soon be able to run solo telehealth practices for anxiety treatment. Until they reach 104 status, they still need physician oversight — but the pathway to independence now exists.

State-Specific Telehealth Prescribing Rules

Federal law sets the baseline, but states add their own layers:

Florida explicitly permits telehealth prescribing of Schedule II drugs for psychiatric conditions — meaning you can treat severe anxiety or comorbid ADHD via video. However, Florida’s out-of-state telehealth registration (which lets non-FL-licensed providers treat Florida patients remotely) prohibits prescribing controlled substances. If you want to prescribe anxiety meds to Florida patients via telehealth, you need a full Florida license.

Texas bans telemedicine treatment of chronic pain with controlled substances — but that doesn’t apply to anxiety treatment. You must establish a valid patient-practitioner relationship via live video before prescribing, and you’re required to check Texas’s PDMP (Prescription Monitoring Program) before writing any controlled substance prescription.

California, New York, Pennsylvania, and Illinois have no special telehealth prescribing restrictions beyond federal requirements. The key compliance requirement across all states: check the state PDMP before prescribing controlled anxiolytics. Every state mandates this for benzodiazepines.

The Economics: What Anxiety Treatment Actually Pays

Let’s talk numbers, because this matters when evaluating telehealth opportunities.

Medicare Reimbursement (2026 Rates)

Medicare actually pays psychiatrists quite well for medication management:

• Initial psychiatric evaluation (90792): ~$202
• 15-minute medication follow-up (99213): ~$95
• 25-minute follow-up (99214): ~$136
• 30-minute therapy add-on (90833): ~$81

Telehealth visits are paid at the same rate as in-person through at least December 2024, with extensions likely continuing into 2026.

For a psychiatrist doing four 15-minute anxiety med checks per hour (realistic with efficient telehealth workflows), you’re looking at ~$380/hour in Medicare revenue before platform fees or overhead.

Medicaid: Lower Rates, Higher Volume

Medicaid pays roughly 50-60% of Medicare rates:

• Initial evaluation: ~$85
• Medication follow-up: ~$40-50

The trade-off is volume. Many telehealth platforms can keep Medicaid psychiatrists’ schedules full because demand far exceeds supply in most states. At 6-8 patients per hour for brief med checks, the math can still work.

Commercial Insurance

Private payers typically pay 100-150% of Medicare rates. Many states now have telehealth parity laws requiring insurers to reimburse virtual visits at the same rate as in-person for mental health services.

The PMHNP Reimbursement Gap

PMHNPs are reimbursed at 85% of physician rates under Medicare when billing under their own NPI. Some practices use ‘incident to’ billing (where the NP’s service bills under a supervising physician’s NPI at 100%), but this is difficult in psychiatry and generally not feasible for telehealth.

The 85% rate is something to factor into compensation negotiations with platforms or employers. However, NP salaries are typically lower than psychiatrist salaries, which balances the economics for group practices.

Why Klarity Makes Economic Sense vs. DIY Marketing

Here’s where we need to have an honest conversation about patient acquisition costs — because a lot of content out there makes telehealth sound cheaper than it is.

The Real Cost of Getting Patients On Your Own

If you’re thinking about building your own telehealth practice and marketing it yourself, let’s look at what that actually costs:

Google Ads for psychiatric keywords: $15-40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ after you account for ad spend, click-through rates, and conversion rates.

SEO: Takes 6-12 months of consistent investment before generating meaningful patient flow. You’ll need:

• Content creation ($1,000-3,000/month for professional writing)
• Technical SEO work ($2,000-5,000 upfront, $500-1,500/month ongoing)
• Link building and ongoing optimization
• Time to actually manage the strategy

Psychology Today and directory listings: Monthly fees ($30-100/month) plus you’re competing with hundreds of other providers on the same page. Conversion rates are unpredictable.

Total realistic DIY marketing spend: $3,000-5,000/month with uncertain results, plus your time managing it all. And you might spend 6 months before seeing consistent patient flow.

The Klarity Model: Pay Only When You See Patients

Klarity operates on a pay-per-appointment model. Instead of gambling $4,000/month on marketing that might not work, you pay a standard listing fee per new patient who actually books with you.

Here’s why that matters:

• No upfront marketing spend — zero risk
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform subscription costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

The economics are straightforward: instead of spending $3,000-5,000/month on marketing with uncertain ROI, you pay only when a qualified anxiety patient books an appointment. That’s guaranteed ROI vs. gambling on marketing channels you may not have expertise in.

For psychiatrists and PMHNPs starting out or scaling their practice, removing the patient acquisition risk entirely changes the math.

Compliance Essentials for Telehealth Anxiety Prescribing

Whether you join a platform or build your own practice, these are non-negotiable:

1. PDMP checks before every controlled substance prescription — required in all states
2. Proper patient evaluation via live video — most states require synchronous audio-visual for initial prescribing
3. State licensure — you must be licensed in the state where the patient is located (not just where you’re sitting)
4. Documentation — telehealth visits require the same clinical documentation as in-person, plus notation that it was conducted via telehealth
5. DEA registration — you need a DEA license in your practicing state to prescribe controlled substances
6. Informed consent — many states and payers require documented patient consent for telehealth treatment

For PMHNPs in collaboration states: ensure your collaborative agreement explicitly covers telehealth practice and the medications you’ll be prescribing.

The Provider Shortage Creates the Opportunity

The demand side of this equation matters. Anxiety disorders are the most common mental health conditions in the U.S., and the provider shortage is severe:

• Texas: One psychiatrist per 8,966 residents
• Florida: One psychiatrist per 8,577 residents
• Illinois: One psychiatrist per 5,849 residents

The national benchmark is around 1:5,000, and most rural areas are far worse.

Telehealth removes geographic barriers. A psychiatrist licensed in Texas and New York can treat patients in both states’ underserved areas without relocating. States participating in the Interstate Medical Licensure Compact (IMLC) — including Texas and Illinois — make it easier to get licensed in multiple states quickly.

What to Watch: Regulatory Changes Coming in 2026

The DEA and HHS are working on permanent telemedicine prescribing regulations to replace the temporary COVID-era flexibilities. Expected changes:

• Special telemedicine prescribing registration for providers
• Possible in-person visit requirements for certain controlled substances or patient populations
• Stricter patient identification and verification requirements

The extension through December 2026 gives regulators time to get this right, but providers should stay alert to updates expected late 2026.

Additionally, Medicare’s in-person visit requirement for tele-mental health (requiring a face-to-face visit within 6 months) has been repeatedly delayed. Current enforcement is postponed through at least September 2025, likely longer. This affects Medicare patients specifically — if it goes into effect, pure-telehealth psychiatrists may need to arrange occasional in-person visits or partner with local providers.

FAQ: Telehealth Anxiety Prescribing

Can psychiatrists prescribe Xanax via telehealth?
Yes. Psychiatrists can prescribe benzodiazepines including Xanax (alprazolam) via telehealth under the federal flexibilities extended through December 2026. You must conduct a proper evaluation, check the state PDMP, and comply with state telehealth laws.

Can PMHNPs prescribe anxiety meds independently?
It depends on the state. In Full Practice Authority states (New York, Arizona, Oregon, etc.), yes — PMHNPs can prescribe all anxiety medications including controlled substances independently. In restricted states (Texas, Florida, Pennsylvania), they need a collaborative agreement with a physician.

Do I need to see anxiety patients in person before prescribing via telehealth?
Not under current federal rules (through 2026). The Ryan Haight Act’s in-person requirement for controlled substances has been suspended. You can conduct the initial evaluation and prescribe controlled anxiolytics entirely via video.

What states allow out-of-state psychiatrists to treat patients via telehealth?
You must be licensed in the state where the patient is located. Florida offers an out-of-state telehealth provider registration, but it prohibits prescribing controlled substances. The Interstate Medical Licensure Compact (IMLC) makes it easier to get licensed in multiple states.

How much can I make treating anxiety via telehealth?
Medicare pays ~$95 for a 15-minute medication follow-up and ~$202 for an initial evaluation. At 4-6 patients per hour for routine med checks, psychiatrists can generate $300-500/hour in gross revenue. Actual take-home depends on platform fees, taxes, and overhead.

Can I prescribe Schedule II stimulants for anxiety via telehealth?
Yes, under current federal rules, though stimulants aren’t first-line for anxiety. Some states (like Texas) restrict PMHNP prescribing of Schedule II drugs — psychiatrists face no such restrictions.

What’s the difference between 103 NP and 104 NP in California?
These are AB 890 categories. A 103 NP (available since Jan 2023) can practice without physician standardized procedures within a group practice. A 104 NP (available Jan 2026) can practice fully independently after 3 years as a 103 NP.

Do telehealth platforms handle PDMP checks?
Platforms typically provide tools or reminders, but the provider is legally responsible for checking the state PDMP before prescribing controlled substances. This is non-delegable.

The Bottom Line for Providers

Treating anxiety via telehealth in 2026 is both legally permissible and economically viable — if you understand the rules and the economics.

Psychiatrists have the broadest authority: you can practice in any state where you’re licensed, prescribe any medication you deem clinically appropriate, and bill at favorable rates through Medicare and commercial insurance.

PMHNPs face state-by-state restrictions: Full Practice Authority states offer parity with psychiatrists, while collaboration states require physician agreements but still allow meaningful independent med management within protocols.

The patient acquisition economics favor platforms like Klarity over DIY marketing for most providers. Spending thousands monthly on ads and SEO with uncertain returns doesn’t make sense when you can join a platform that delivers pre-qualified patients and you only pay when they book.

The regulatory landscape is in flux — the 2026 DEA rules will shape the next chapter of telehealth prescribing — but the fundamentals are clear: there’s massive demand, you have the clinical authority to meet it, and the reimbursement supports it.

Ready to start treating anxiety patients via telehealth without the marketing gamble? Explore joining Klarity’s provider network — vetted patients, compliant infrastructure, and you only pay when you see appointments. Learn more about becoming a Klarity provider.

References and Sources

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (hhs.gov): https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html — Official government source on federal telehealth prescribing policy through December 2026.

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (flsenate.gov): https://www.flsenate.gov/laws/statutes/2024/464.012 and https://www.flsenate.gov/laws/statutes/2022/456.47 — Florida state law defining PMHNP scope and telehealth prescribing rules.

3. California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov): https://rn.ca.gov/practice/ab890.shtml — Official state guidance on 103 NP and 104 NP independent practice categories.

4. NPNY Announcement – ‘NP Modernization Act Passes in NY’ (npny.enpnetwork.com): https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes — April 2022 announcement of New York’s Full Practice Authority law.

5. Texas Medical Board FAQ – NP Prescribing of Schedule II (tmb.state.tx.us): https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation — Official guidance on physician delegation limits for controlled substances in Texas.

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs